Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9443770 | 0.87 | ALDH1A1 (0.38) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL9443817 | 0.85 | TSHR (0.39) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL9443803 | 0.85 | LMNA (0.39) | MAPTHPGDSMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL9443793 | 0.85 | ALDH1A1 (0.39) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL9443831 | 0.85 | ACHE (0.39) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL9443804 | 0.85 | NR1H2 (0.39) | MAPTHPGDHSD17B10ALDH1A1 | |
| SCHEMBL9443806 | 0.83 | KMT2A (0.37) | MAPTHPGDSMN1; SMN2ALDH1A1 | |
| SCHEMBL9443807 | 0.82 | ALDH1A1 (0.36) | MAPTSMN1; SMN2ALDH1A1MAPK1TSHR | |
| SCHEMBL9443838 | 0.82 | TSHR (0.35) | MAPTALDH1A1MAPK1TSHR | |
| SCHEMBL10525723 | 0.80 | CA4 (0.45) | MAPTSMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374535-A1 | COMPOSITIONS AND METHODS FOR TREATING BIOFILM DISORDERS AND INFECTIONS | AHV International B.V. (NL) | 2024-11-14 | — | — | US | disclosed |
| CN-114583264-B | Electrolyte additive, electrolyte and lithium ion battery | 比亚迪股份有限公司 | 2024-09-10 | — | — | CN | disclosed |
| CN-114583264-A | Electrolyte additive, electrolyte and lithium ion battery | 比亚迪股份有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-111918899-A | Cured product of resin composition, laminate, and resin composition | 日本板硝子株式会社 | 2020-11-10 | — | — | CN | disclosed |
| CN-110885401-A | Copolymer, curable resin composition containing same, and cured product thereof | 株式会社大赛璐 | 2020-03-17 | — | — | CN | disclosed |
| CN-106986803-A | Cationic sulfoxide intermediate, polyarylene sulfide monomer and preparation method of polyarylene sulfide | 财团法人工业技术研究院 | 2017-07-28 | — | — | CN | disclosed |
| WO-2014210132-A2 | VALENCY DEPENDENT BIOACTIVE HYDROXYAPATITE-BINDING DENDRONS | THE UNIVERSITY OF AKRON (US) | 2014-12-31 | — | — | WO | disclosed |
| US-20030232994-A1 | Bicyclic thiophene derivatives and combinatorial libraries thereof | LION BIOSCIENCE AG (DE) | 2003-12-18 | — | — | US | disclosed |
| EP-0686160-A4 | SOLUTION AND SOLID-PHASE FORMATION OF GLYCOSIDIC LINKAGES | UNIV PRINCETON (US) | 2003-03-12 | — | — | EP | disclosed |
| US-6194393-B1 | A GLYCOSIDE CONTAINING AN ANOMERIC SULFOXIDE AND NUCLEOPHILIC FUNCTIONAL GROUPS AND HAVING POTENTIAL GLYCOSYL ACCEPTING/DONATING CHARACTERISTICS AND AN ACTIVATING AGENT; RAPID CONSTRUCTION OLIGOSACCHARIDES; GLYCOSYLATION; LIBRARY | THE TRUSTEES OF PRINCETON UNIVERSITY | 2001-02-27 | — | — | US | disclosed |
| US-5700916-A | INTERMEDIATES FOR FORMING OLIGOSACCHARIDES, INCLUDING 4-HYDROXYTHIOPHENYL-/2-AZIDO-2-DEOXYGLUCO/PYRANOSIDE | TRUSTEES OF PRINCETON UNIVERSITY (US) | 1997-12-23 | — | — | US | disclosed |
| US-5639866-A | EXPOSING GLYCOSYL ACCEPTOR BOUND TO SOLID SUPPORT TO GLYCOSIDE HAVING ACTIVATED ANOMERIC SULFOXIDE GROUP, FORMING GLYCOSIDIC BOND | PRINCETON UNIVERSITY (US) | 1997-06-17 | — | — | US | disclosed |
| US-5635612-A | Method of forming multiple glycosidic linkages in a single step | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1997-06-03 | — | — | US | disclosed |
| EP-0686160-A1 | SOLUTION AND SOLID-PHASE FORMATION OF GLYCOSIDIC LINKAGES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1995-12-13 | — | — | EP | disclosed |
| WO-1994019360-A1 | SOLUTION AND SOLID-PHASE FORMATION OF GLYCOSIDIC LINKAGES | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 1994-09-01 | — | — | WO | disclosed |
| US-5321045-A | PAF-induced bronchial obstructions | BOEHRINGER MANNHEIM GMBH (DE) | 1994-06-14 | — | — | US | disclosed |
| EP-0299424-B1 | Thiosulfinic-acid derivatives, and the use of thiosulfin-acid derivatives for the manufacture of a medicament for the treatment of inflammatory diseases | BOEHRINGER MANNHEIM GMBH (DE) | 1993-10-20 | — | — | EP | disclosed |
| EP-0324023-A1 | THIOSULPHINIC ACID DERIVATIVES, THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES, AND DRUGS CONTAINING THEM | Roche Diagnostics GmbH (DE) | 1989-07-19 | — | — | EP | disclosed |
| WO-1989000422-A2 | THIOSULPHINIC ACID DERIVATIVES, THEIR USE IN THE TREATMENT OF INFLAMMATORY DISEASES, AND DRUGS CONTAINING THEM | BOEHRINGER MANNHEIM GMBH (DE) | 1989-01-26 | — | — | WO | disclosed |
| EP-0299424-A2 | Thiosulfinic-acid derivatives, and the use of thiosulfin-acid derivatives for the manufacture of a medicament for the treatment of inflammatory diseases | Roche Diagnostics GmbH (DE) | 1989-01-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030232994-A1 | Bicyclic thiophene derivatives and combinatorial libraries thereof | CXCR2, BICRA, CXCR1 | MAPT 2743/4885HPGD 3319/4885SMN1; SMN2 4658/4885 |
| US-20240374535-A1 | COMPOSITIONS AND METHODS FOR TREATING BIOFILM DISORDERS AND INFECTIONS | TST, MYD88, BTK | MAPT 3417/4885HPGD 2116/4885SMN1; SMN2 4709/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.